cardiac malformation

Clinical Update 2024: Gabapentin (Neurontin) and Pregnancy

In this study with over 4000 infants exposed to gabapentin, the information is reassuring.  While we cannot rule out the possibility of a small increase in risk of cardiovascular malformations in gabapentin-exposed infants, gabapentin does not appear to be a major teratogen. 

By |2025-06-26T08:06:00-04:00October 23rd, 2024|Women's Mental Health|Comments Off on Clinical Update 2024: Gabapentin (Neurontin) and Pregnancy

Essential Reads: More Data on ADHD Medications and Pregnancy

Women with attention-deficit/hyperactivity disorder (ADHD) often discontinue psychostimulant  medications during pregnancy, especially if they have milder symptoms.  While this approach makes sense in terms of limiting unnecessary exposures in women with what appears to [...]

By |2021-01-19T10:49:57-04:00January 20th, 2021|ADHD Medications, Essential Reads, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Essential Reads: More Data on ADHD Medications and Pregnancy

Good News: More Data on the Use of ADHD Medications During Pregnancy

For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we often recommend discontinuing stimulant medications and switching to a non-pharmacologic intervention.  Many women experience some decrease in their level of functioning; however, they are [...]

By |2019-10-15T15:57:57-04:00December 22nd, 2017|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Good News: More Data on the Use of ADHD Medications During Pregnancy
Go to Top